Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 4 | 2018 | 679 | 1.480 |
Why?
|
| Glutamine | 4 | 2022 | 211 | 1.410 |
Why?
|
| Telomere | 3 | 2015 | 222 | 1.180 |
Why?
|
| DNA | 3 | 2015 | 1473 | 0.890 |
Why?
|
| RecQ Helicases | 2 | 2015 | 64 | 0.880 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 140 | 0.790 |
Why?
|
| Fatty Acids | 1 | 2025 | 356 | 0.770 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1657 | 0.710 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 2645 | 0.650 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 201 | 0.640 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 444 | 0.580 |
Why?
|
| Ephrin-A2 | 1 | 2017 | 3 | 0.560 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 441 | 0.560 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 75 | 0.550 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 270 | 0.540 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 1576 | 0.510 |
Why?
|
| Werner Syndrome | 1 | 2015 | 2 | 0.480 |
Why?
|
| Exodeoxyribonucleases | 1 | 2015 | 52 | 0.470 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1047 | 0.470 |
Why?
|
| Phosphoproteins | 1 | 2017 | 442 | 0.470 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 728 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 571 | 0.450 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2014 | 5 | 0.440 |
Why?
|
| Receptor, EphA2 | 3 | 2020 | 28 | 0.430 |
Why?
|
| G-Quadruplexes | 1 | 2014 | 12 | 0.430 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 441 | 0.420 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 685 | 0.420 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 624 | 0.420 |
Why?
|
| TATA-Box Binding Protein | 1 | 2013 | 31 | 0.410 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 90 | 0.410 |
Why?
|
| RANK Ligand | 1 | 2013 | 54 | 0.400 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 89 | 0.400 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2013 | 162 | 0.400 |
Why?
|
| Protein Folding | 1 | 2013 | 223 | 0.380 |
Why?
|
| DNA Replication | 1 | 2014 | 353 | 0.360 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 429 | 0.360 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1825 | 0.350 |
Why?
|
| DNA Damage | 1 | 2014 | 511 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 2438 | 0.330 |
Why?
|
| Glutaminase | 2 | 2022 | 17 | 0.330 |
Why?
|
| Progesterone | 3 | 2018 | 451 | 0.320 |
Why?
|
| Epithelial Cells | 1 | 2013 | 903 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2019 | 4703 | 0.290 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 3678 | 0.260 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2025 | 167 | 0.250 |
Why?
|
| Mice | 9 | 2025 | 18461 | 0.250 |
Why?
|
| Animals | 11 | 2025 | 34785 | 0.240 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2025 | 12 | 0.230 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 719 | 0.230 |
Why?
|
| Everolimus | 1 | 2025 | 50 | 0.230 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 764 | 0.180 |
Why?
|
| Female | 9 | 2025 | 70592 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2025 | 526 | 0.180 |
Why?
|
| Bone and Bones | 1 | 2023 | 301 | 0.170 |
Why?
|
| Amino Acids | 1 | 2023 | 626 | 0.170 |
Why?
|
| Protein Binding | 2 | 2016 | 1730 | 0.170 |
Why?
|
| Phospholipase C gamma | 1 | 2020 | 29 | 0.160 |
Why?
|
| Heterografts | 1 | 2021 | 197 | 0.160 |
Why?
|
| Neoplasm Transplantation | 1 | 2021 | 382 | 0.160 |
Why?
|
| Humans | 13 | 2025 | 131934 | 0.160 |
Why?
|
| MTOR Associated Protein, LST8 Homolog | 1 | 2019 | 1 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2019 | 1044 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2019 | 30 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 230 | 0.150 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 105 | 0.140 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 6 | 0.140 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 39 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4682 | 0.130 |
Why?
|
| Breast | 1 | 2018 | 215 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 258 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 663 | 0.130 |
Why?
|
| Gastroenteritis | 1 | 2019 | 365 | 0.130 |
Why?
|
| Ephrin-A1 | 1 | 2016 | 2 | 0.120 |
Why?
|
| Estrogens | 1 | 2018 | 435 | 0.120 |
Why?
|
| Werner Syndrome Helicase | 1 | 2015 | 3 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 70 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2444 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2507 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 406 | 0.110 |
Why?
|
| Biocatalysis | 1 | 2014 | 35 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2015 | 292 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2017 | 712 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 302 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1161 | 0.100 |
Why?
|
| Progestins | 1 | 2013 | 45 | 0.100 |
Why?
|
| Prolactin | 1 | 2013 | 113 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 632 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 246 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 876 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1117 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2312 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2014 | 347 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 348 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2221 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 291 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 810 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 526 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1443 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1045 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1535 | 0.080 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 453 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2017 | 3860 | 0.080 |
Why?
|
| Base Sequence | 1 | 2014 | 2899 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1977 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2669 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1304 | 0.070 |
Why?
|
| Gene Expression | 1 | 2013 | 1558 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2955 | 0.070 |
Why?
|
| Cell Line | 1 | 2013 | 2719 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2493 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2013 | 3037 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2020 | 1608 | 0.060 |
Why?
|
| Risk Factors | 1 | 2018 | 10935 | 0.050 |
Why?
|
| Leptin | 1 | 2022 | 219 | 0.040 |
Why?
|
| Male | 2 | 2023 | 64877 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 166 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 750 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 227 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 500 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 990 | 0.030 |
Why?
|
| Tenascin | 1 | 2015 | 32 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1555 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 75 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 56 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 176 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 303 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 240 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2015 | 418 | 0.020 |
Why?
|
| Apoptosis | 1 | 2019 | 1891 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3175 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2056 | 0.020 |
Why?
|